bit.bio launches new custom disease model cells offering, advancing disease research & drug discovery

bit.bio, the cell coding company today launches its new Custom ioDisease Model CellsTM offering. This offering allows scientists to commission their disease-relevant mutation of interest in bit.bio's human induced pluripotent stem cell (iPSC)-derived cells powered by opti-ox technology

Image Credit: bit.bio/Shutterstock.com

Image Credit: bit.bio

The disease-relevant mutation is engineered into bit.bio’s human ioWild TypeTM cells using CRISPR/Cas9 gene editing. As disease model cells come from an identical human genetic background to ioWild Type cells, any experimental differences observed between the wild type and the disease model can be confidently attributed to the effects caused by the disease-specific mutations.

bit.bio’s cells are precision reprogrammed by opti-ox, which enables the manufacturing of any human cell type at scale with precision and consistency. These key features make the models ideally suited to screening applications for early drug discovery as well as for fundamental research. Scientists receive defined, consistent, ready-to-use cells, empowering them to investigate the impact of their mutation in a human context. 

Due to a lack of standardised, easy to use and readily accessible human cell models, scientists have relied on animal models and cell lines that differ considerably from human biology. iPSC-derived cells from patients offer a human model for disease research, but sourcing them with the disease-specific mutation of interest can be a complex and time-consuming process. These cells also often lack standardisation and optimised, fast protocols, making it difficult to generate consistent data and scalable disease models. 

This offering provides scientists with a powerful tool to overcome these limitations.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    bit.bio. (2023, May 25). bit.bio launches new custom disease model cells offering, advancing disease research & drug discovery. News-Medical. Retrieved on June 12, 2024 from https://www.news-medical.net/news/20230524/bitbio-launches-new-custom-disease-model-cells-offering-advancing-disease-research-drug-discovery.aspx.

  • MLA

    bit.bio. "bit.bio launches new custom disease model cells offering, advancing disease research & drug discovery". News-Medical. 12 June 2024. <https://www.news-medical.net/news/20230524/bitbio-launches-new-custom-disease-model-cells-offering-advancing-disease-research-drug-discovery.aspx>.

  • Chicago

    bit.bio. "bit.bio launches new custom disease model cells offering, advancing disease research & drug discovery". News-Medical. https://www.news-medical.net/news/20230524/bitbio-launches-new-custom-disease-model-cells-offering-advancing-disease-research-drug-discovery.aspx. (accessed June 12, 2024).

  • Harvard

    bit.bio. 2023. bit.bio launches new custom disease model cells offering, advancing disease research & drug discovery. News-Medical, viewed 12 June 2024, https://www.news-medical.net/news/20230524/bitbio-launches-new-custom-disease-model-cells-offering-advancing-disease-research-drug-discovery.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
bit.bio launches Huntington’s disease human cell model